81_FR_23071 81 FR 22996 - National Institute of Diabetes and Digestive and Kidney Diseases Notice of Closed Meeting

81 FR 22996 - National Institute of Diabetes and Digestive and Kidney Diseases Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 75 (April 19, 2016)

Page Range22996-22997
FR Document2016-08996

Federal Register, Volume 81 Issue 75 (Tuesday, April 19, 2016)
[Federal Register Volume 81, Number 75 (Tuesday, April 19, 2016)]
[Notices]
[Pages 22996-22997]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-08996]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NEW NIDDK PARs on 
Pragmatic Research and Natural Experiments.
    Date: May 13, 2016.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7353, 6707 Democracy Boulevard,

[[Page 22997]]

Bethesda, MD 20892-2542, (301) 594-8898, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: April 13, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-08996 Filed 4-18-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                  22996                          Federal Register / Vol. 81, No. 75 / Tuesday, April 19, 2016 / Notices

                                                  Bethesda, MD 20892–5452, (301) 594–4719,                (Catalogue of Federal Domestic Assistance             campus. Visitors will be asked to show one
                                                  guox@extra.niddk.nih.gov.                               Program Nos. 93.847, Diabetes,                        form of identification (for example, a
                                                    Name of Committee: National Institute of              Endocrinology and Metabolic Research;                 government-issued photo ID, driver’s license,
                                                  Diabetes and Digestive and Kidney Diseases              93.848, Digestive Diseases and Nutrition              or passport) and to state the purpose of their
                                                  Special Emphasis Panel; NIDDK Member                    Research; 93.849, Kidney Diseases, Urology            visit.
                                                  Conflict SEP.                                           and Hematology Research, National Institutes            Information is also available on the
                                                    Date: June 3, 2016.                                   of Health, HHS)                                       Institute’s/Center’s home page: http://
                                                    Time: 9:00 a.m. to 5:00 p.m.                                                                                deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
                                                    Agenda: To review and evaluate grant                    Dated: April 13, 2016.                              where an agenda and any additional
                                                  applications.                                           David Clary,                                          information for the meeting will be posted
                                                    Place: Melrose Hotel, 2430 Pennsylvania               Program Analyst, Office of Federal Advisory           when available.
                                                  Ave. NW., Washington, DC 20037.                         Committee Policy.                                     (Catalogue of Federal Domestic Assistance
                                                    Contact Person: Xiaodu Guo, MD, Ph.D.,                [FR Doc. 2016–08995 Filed 4–18–16; 8:45 am]           Program Nos. 93.392, Cancer Construction;
                                                  Scientific Review Officer, Review Branch,                                                                     93.393, Cancer Cause and Prevention
                                                                                                          BILLING CODE 4140–01–P
                                                  DEA, NIDDK, National Institutes of Health,                                                                    Research; 93.394, Cancer Detection and
                                                  Room 7023, 6707 Democracy Boulevard,                                                                          Diagnosis Research; 93.395, Cancer
                                                  Bethesda, MD 20892–5452, (301) 594–4719,                                                                      Treatment Research; 93.396, Cancer Biology
                                                  guox@extra.niddk.nih.gov.                               DEPARTMENT OF HEALTH AND                              Research; 93.397, Cancer Centers Support;
                                                                                                          HUMAN SERVICES                                        93.398, Cancer Research Manpower; 93.399,
                                                    Name of Committee: National Institute of
                                                  Diabetes and Digestive and Kidney Diseases                                                                    Cancer Control, National Institutes of Health,
                                                                                                          National Institutes of Health                         HHS)
                                                  Special Emphasis Panel; RFA–DK–15–027:
                                                  Human Pancreas Procurement and Analysis                 National Cancer Institute; Notice of                    Dated: April 13, 2016.
                                                  Program (HPPAP) (UC4].
                                                                                                          Open Meeting                                          Melanie J. Gray,
                                                    Date: June 6, 2016.
                                                    Time: 10:00 a.m. to 12:30 p.m.                                                                              Program Analyst, Office of Federal Advisory
                                                                                                             Pursuant to section 10(a) of the                   Committee Policy.
                                                    Agenda: To review and evaluate                        Federal Advisory Committee Act, as
                                                  cooperative agreement applications.                     amended (5 U.S.C. App.), notice is
                                                                                                                                                                [FR Doc. 2016–08949 Filed 4–18–16; 8:45 am]
                                                    Place: National Institutes of Health, Two                                                                   BILLING CODE 4140–01–P
                                                  Democracy Plaza, 6707 Democracy
                                                                                                          hereby given of a meeting of the
                                                  Boulevard, Bethesda, MD 20892 (Telephone                National Cancer Institute Clinical Trials
                                                  Conference Call).                                       and Translational Research Advisory
                                                                                                                                                                DEPARTMENT OF HEALTH AND
                                                    Contact Person: Najma Begum, Ph.D.,                   Committee.
                                                                                                             The meeting will be open to the                    HUMAN SERVICES
                                                  Scientific Review Officer, Review Branch,
                                                  DEA, NIDDK, National Institutes of Health,              public, with attendance limited to space              National Institutes of Health
                                                  Room 7349, 6707 Democracy Boulevard,                    available. Individuals who plan to
                                                  BETHESDA, MD 20892–5452, (301) 594–                     attend and need special assistance, such              National Institute of Diabetes and
                                                  8894, begumn@niddk.nih.gov.                             as sign language interpretation or other              Digestive and Kidney Diseases Notice
                                                    Name of Committee: National Institute of              reasonable accommodations, should                     of Closed Meeting
                                                  Diabetes and Digestive and Kidney Diseases              notify the Contact Person listed below
                                                  Special Emphasis Panel; RFA DK–15–025:                                                                          Pursuant to section 10(d) of the
                                                                                                          in advance of the meeting. The meeting
                                                  Mechanisms Underlying the Contribution of                                                                     Federal Advisory Committee Act, as
                                                  Type 1 Diabetes Risk-Associated Variants                will also be videocast and can be
                                                                                                          accessed from the NIH Videocasting and                amended (5 U.S.C. App.), notice is
                                                  (DP3).                                                                                                        hereby given of the following meeting.
                                                    Date: June 23, 2016.                                  Podcasting Web site (http://
                                                                                                          videocast.nih.gov/).                                    The meeting will be closed to the
                                                    Time: 10:00 a.m. to 3:00 p.m.
                                                    Agenda: To review and evaluate grant                                                                        public in accordance with the
                                                                                                            Name of Committee: National Cancer                  provisions set forth in sections
                                                  applications.                                           Institute Clinical Trials and Translational
                                                    Place: National Institutes of Health, Two                                                                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                          Research Advisory Committee.
                                                  Democracy Plaza, 6707 Democracy                           Date: July 13, 2016.                                as amended. The grant applications and
                                                  Boulevard, Bethesda, MD 20892 (Telephone                  Time: 8:00 a.m. to 4:00 p.m.                        the discussions could disclose
                                                  Conference Call).                                         Agenda: Strategic Discussion of NCI’s               confidential trade secrets or commercial
                                                    Contact Person: Najma Begum, Ph.D.,                   Clinical and Translational Research                   property such as patentable material,
                                                  Scientific Review Officer, Review Branch,               Programs.                                             and personal information concerning
                                                  DEA, NIDDK, National Institutes of Health,                Place: National Institutes of Health,               individuals associated with the grant
                                                  Room 7349, 6707 Democracy Boulevard,                    Building 31, C–Wing, 6th Floor, Room 9 and
                                                  Bethesda, MD 20892–5452, (301) 594–8894,                                                                      applications, the disclosure of which
                                                                                                          10, 31 Center Drive, Bethesda, MD 20892.
                                                  begumn@niddk.nih.gov.                                                                                         would constitute a clearly unwarranted
                                                                                                             Contact Person: Sheila A. Prindiville, MD,
                                                    Name of Committee: National Institute of              MPH Director, Coordinating Center for                 invasion of personal privacy.
                                                  Diabetes and Digestive and Kidney Diseases              Clinical Trials, National Institutes of Health,         Name of Committee: National Institute of
                                                  Special Emphasis Panel; George M. O’Brien               National Cancer Institute, 9609 Medical               Diabetes and Digestive and Kidney Diseases
                                                  Urology Cooperative Research Centers                    Center Drive, Room 6W136, Rockville, MD               Special Emphasis Panel; NEW NIDDK PARs
                                                  Program (U54).                                          20850, 240–276–6173, prindivs@                        on Pragmatic Research and Natural
                                                    Date: July 12, 2016.                                  mail.nih.gov.                                         Experiments.
                                                    Time: 8:00 a.m. to 7:00 p.m.                             Any interested person may file written               Date: May 13, 2016.
                                                    Agenda: To review and evaluate grant                  comments with the committee by forwarding               Time: 10:00 a.m. to 5:00 p.m.
                                                  applications.                                           the statement to the Contact Person listed on           Agenda: To review and evaluate grant
                                                    Place: Residence Inn Capital View, 2850                                                                     applications.
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                                                                          this notice. The statement should include the
                                                  South Potomac Avenue, Arlington, VA                     name, address, telephone number and when                Place: National Institutes of Health, Two
                                                  22202.                                                  applicable, the business or professional              Democracy Plaza, 6707 Democracy
                                                    Contact Person: Jason D. Hoffert, Ph.D.,              affiliation of the interested person.                 Boulevard, Bethesda, MD 20892 (Telephone
                                                  Scientific Review Officer, Review Branch,                  In the interest of security, NIH has               Conference Call).
                                                  DEA, NIDDK, National Institutes of Health,              instituted stringent procedures for entrance            Contact Person: Michele L. Barnard, Ph.D.,
                                                  Room 7343, 6707 Democracy Boulevard,                    onto the NIH campus. All visitor vehicles,            Scientific Review Officer, Review Branch,
                                                  Bethesda, MD 20817, 301–496–9010,                       including taxicabs, hotel, and airport shuttles       DEA, NIDDK, National Institutes of Health,
                                                  hoffertj@niddk.nih.gov.                                 will be inspected before being allowed on             Room 7353, 6707 Democracy Boulevard,



                                             VerDate Sep<11>2014   18:02 Apr 18, 2016   Jkt 238001   PO 00000   Frm 00033   Fmt 4703   Sfmt 4703   E:\FR\FM\19APN1.SGM   19APN1


                                                                                 Federal Register / Vol. 81, No. 75 / Tuesday, April 19, 2016 / Notices                                                 22997

                                                  Bethesda, MD 20892–2542, (301) 594–8898,                MSC 7892, Bethesda, MD 20892, 301–435–                DEPARTMENT OF HEALTH AND
                                                  barnardm@extra.niddk.nih.gov.                           2902, filpuladr@mail.nih.gov.                         HUMAN SERVICES
                                                  (Catalogue of Federal Domestic Assistance               (Catalogue of Federal Domestic Assistance
                                                  Program Nos. 93.847, Diabetes,                          Program Nos. 93.306, Comparative Medicine;            National Institutes of Health
                                                  Endocrinology and Metabolic Research;                   93.333, Clinical Research, 93.306, 93.333,
                                                  93.848, Digestive Diseases and Nutrition                93.337, 93.393–93.396, 93.837–93.844,                 National Institute of Biomedical
                                                  Research; 93.849, Kidney Diseases, Urology              93.846–93.878, 93.892, 93.893, National               Imaging and Bioengineering; Notice of
                                                  and Hematology Research, National Institutes            Institutes of Health, HHS)
                                                                                                                                                                Closed Meeting
                                                  of Health, HHS)                                           Dated: April 13, 2016.
                                                    Dated: April 13, 2016.                                David Clary,
                                                                                                                                                                  Pursuant to section 10(d) of the
                                                                                                                                                                Federal Advisory Committee Act, as
                                                  David Clary,                                            Program Analyst, Office of Federal Advisory
                                                                                                          Committee Policy.
                                                                                                                                                                amended (5 U.S.C. App.), notice is
                                                  Program Analyst, Office of Federal Advisory                                                                   hereby given of the following meeting.
                                                  Committee Policy.                                       [FR Doc. 2016–08991 Filed 4–18–16; 8:45 am]
                                                                                                                                                                  The meeting will be closed to the
                                                  [FR Doc. 2016–08996 Filed 4–18–16; 8:45 am]             BILLING CODE 4140–01–P
                                                                                                                                                                public in accordance with the
                                                  BILLING CODE 4140–01–P                                                                                        provisions set forth in sections
                                                                                                                                                                552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                          DEPARTMENT OF HEALTH AND
                                                                                                                                                                as amended. The grant applications and
                                                  DEPARTMENT OF HEALTH AND                                HUMAN SERVICES
                                                                                                                                                                the discussions could disclose
                                                  HUMAN SERVICES                                                                                                confidential trade secrets or commercial
                                                                                                          National Institutes of Health
                                                  National Institutes of Health                                                                                 property such as patentable material,
                                                                                                          National Institute of Allergy and                     and personal information concerning
                                                  Center for Scientific Review; Notice of                 Infectious Diseases; Notice of Closed                 individuals associated with the grant
                                                  Closed Meetings                                         Meeting                                               applications, the disclosure of which
                                                                                                                                                                would constitute a clearly unwarranted
                                                    Pursuant to section 10(d) of the                        Pursuant to section 10(d) of the                    invasion of personal privacy.
                                                  Federal Advisory Committee Act, as                      Federal Advisory Committee Act, as
                                                                                                          amended (5 U.S.C. App.), notice is                      Name of Committee: National Institute of
                                                  amended (5 U.S.C. App.), notice is                                                                            Biomedical Imaging and Bioengineering
                                                  hereby given of the following meetings.                 hereby given of the following meeting.
                                                                                                                                                                Special Emphasis Panel; NIBIB P41 Site Visit
                                                                                                            The meeting will be closed to the                   (2016/10).
                                                    The meetings will be closed to the                    public in accordance with the
                                                  public in accordance with the                                                                                   Date: May 1–3, 2016.
                                                                                                          provisions set forth in sections                        Time: 6:00 p.m. to 12:00 p.m.
                                                  provisions set forth in sections                        552b(c)(4) and 552b(c)(6), title 5 U.S.C.,              Agenda: To review and evaluate grant
                                                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              as amended. The grant applications and                applications.
                                                  as amended. The grant applications and                  the discussions could disclose                          Place: Dallas Marriott Suites Medical/
                                                  the discussions could disclose                          confidential trade secrets or commercial              Market Center, 2493 North Stemmons
                                                  confidential trade secrets or commercial                                                                      Freeway, Dallas, TX 75207.
                                                                                                          property such as patentable material,
                                                  property such as patentable material,                                                                           Contact Person: Ruixia Zhou, Ph.D.,
                                                                                                          and personal information concerning                   Scientific Review Officer, 6707 Democracy
                                                  and personal information concerning                     individuals associated with the grant                 Boulevard, Democracy Two Building, Suite
                                                  individuals associated with the grant                   applications, the disclosure of which                 967, Bethesda, MD 20892, (301) 496–4773,
                                                  applications, the disclosure of which                   would constitute a clearly unwarranted                zhour@mail.nih.gov.
                                                  would constitute a clearly unwarranted                  invasion of personal privacy.                           This notice is being published less than 15
                                                  invasion of personal privacy.                                                                                 days prior to the meeting due to the timing
                                                                                                            Name of Committee: National Institute of
                                                    Name of Committee: Center for Scientific              Allergy and Infectious Diseases Special               limitations imposed by the review and
                                                  Review Special Emphasis Panel; Great                    Emphasis Panel; ‘‘NIAID Investigator                  funding cycle.
                                                  Challenge Synthetic Biology Program Project.            Initiated Program Project Applications (P01)’’
                                                    Date: May 19–20, 2016.                                                                                        Dated: April 13, 2016.
                                                                                                            Date: May 12, 2016.
                                                    Time: 8:00 a.m. to 5:00 p.m.                            Time: 11:00 a.m. to 5:00 p.m.                       David Clary,
                                                    Agenda: To review and evaluate grant                    Agenda: To review and evaluate grant                Program Analyst, Office of Federal Advisory
                                                  applications.                                           applications.                                         Committee Policy.
                                                    Place: National Institutes of Health, 6701              Place: National Institutes of Health, Room          [FR Doc. 2016–08994 Filed 4–18–16; 8:45 am]
                                                  Rockledge Drive, Bethesda, MD 20892                     3F100, 5601 Fishers Lane, Rockville, MD
                                                                                                                                                                BILLING CODE 4140–01–P
                                                  (Virtual Meeting).                                      20892, (Telephone Conference Call).
                                                    Contact Person: Sergei Ruvinov, Ph.D.,                  Contact Person: Jay R. Radke, Ph.D.,
                                                  Scientific Review Officer, Center for                   Scientific Review Officer, Scientific Review
                                                  Scientific Review, National Institutes of               Program, Division of Extramural Activities,           DEPARTMENT OF HEALTH AND
                                                  Health, 6701 Rockledge Drive, Room 4158,                Room #3G11B, National Institutes of Health,           HUMAN SERVICES
                                                  MSC 7806, Bethesda, MD 20892, 301–435–                  NIAID, 5601 Fishers Lane MSC–9823,
                                                  1180, ruvinser@csr.nih.gov.                             Bethesda, MD 20892–9823, (240) 669–5046,              National Institutes of Health
                                                                                                          jay.radke@nih.gov.
                                                    Name of Committee: Center for Scientific                                                                    Prospective Grant of Exclusive
                                                  Review Special Emphasis Panel; PAR Panel:               (Catalogue of Federal Domestic Assistance
                                                                                                          Program Nos. 93.855, Allergy, Immunology,             License: The Development of MRI–
                                                  High Throughput Screening.
                                                    Date: May 19, 2016.                                   and Transplantation Research; 93.856,                 1569, MRI–2213 and MRI–2214 as a
                                                    Time: 8:00 a.m. to 6:00 p.m.                          Microbiology and Infectious Diseases                  Therapeutic To Treat Obesity,
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                    Agenda: To review and evaluate grant                  Research, National Institutes of Health, HHS)         Diabetes, Fatty Liver Disease and Liver
                                                  applications.                                             Dated: April 14, 2016.                              Fibrosis
                                                    Place: Residence Inn Bethesda, 7335                   Natasha M. Copeland,
                                                  Wisconsin Avenue, Bethesda, MD 20814.
                                                                                                                                                                AGENCY:  National Institutes of Diabetes
                                                    Contact Person: David Filpula, Ph.D.,                 Program Analyst, Office of Federal Advisory           and Digestive and Kidney Diseases,
                                                  Scientific Review Officer, Center for                   Committee Policy.                                     Public Health Service, PHS, National
                                                  Scientific Review, National Institutes of               [FR Doc. 2016–08993 Filed 4–18–16; 8:45 am]           Institutes of Health, Department of
                                                  Health, 6701 Rockledge Drive, Room 6181,                BILLING CODE 4140–01–P                                Health and Human Services.


                                             VerDate Sep<11>2014   18:02 Apr 18, 2016   Jkt 238001   PO 00000   Frm 00034   Fmt 4703   Sfmt 4703   E:\FR\FM\19APN1.SGM   19APN1



Document Created: 2016-04-19 00:16:03
Document Modified: 2016-04-19 00:16:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 13, 2016.
FR Citation81 FR 22996 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR